Finance

Lists
BIOG-B:STO
BioGaia AB
118,30 SEK
+1,28%
(+1,50) 1D
12 ოქტ, 17:29:40 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for BIOG-B...
Open
116,80 SEK
High
118,80 SEK
Low
115,80 SEK
Mkt. cap
11,50 მლრდ.
Avg. vol.
165,98 ათ.
Volume
84,38 ათ.
52-wk high
136,30 SEK
52-wk low
96,20 SEK
Shares outstanding
98,50 მლნ.
No. of employees
251
Open
116,80 SEK
High
118,80 SEK
Low
115,80 SEK
Mkt. cap
11,50 მლრდ.
Avg. vol.
165,98 ათ.
Volume
84,38 ათ.
52-wk high
136,30 SEK
52-wk low
96,20 SEK
Shares outstanding
98,50 მლნ.
No. of employees
251
News stories
From web sources and news partners
Profile
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
About BioGaia AB
CEOTheresa Agnew
Employees251
Founded1990
Headquarters-
Sector-
Websitebiogaiagroup.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
326,64 მლნ.
440,57 მლნ.
372,55 მლნ.
440,86 მლნ.
Cost of goods sold
84,13 მლნ.
116,74 მლნ.
105,77 მლნ.
119,98 მლნ.
Cost of revenue
84,13 მლნ.
116,74 მლნ.
105,77 მლნ.
119,98 მლნ.
Research and development expenses
25,88 მლნ.
36,79 მლნ.
25,53 მლნ.
28,24 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
126,67 მლნ.
159,68 მლნ.
145,89 მლნ.
167,47 მლნ.
Operating expense
152,54 მლნ.
196,47 მლნ.
171,42 მლნ.
195,71 მლნ.
Total operating expenses
236,68 მლნ.
313,21 მლნ.
277,19 მლნ.
315,69 მლნ.
Operating income
89,96 მლნ.
127,36 მლნ.
95,36 მლნ.
125,17 მლნ.
Other non operating income
1,00 ათ.
-2,39 მლნ.
285,00 ათ.
-1,00 ათ.
EBT including unusual items
85,32 მლნ.
123,58 მლნ.
101,50 მლნ.
134,03 მლნ.
EBT excluding unusual items
87,52 მლნ.
117,88 მლნ.
103,78 მლნ.
134,03 მლნ.
Income tax expense
19,44 მლნ.
24,80 მლნ.
22,10 მლნ.
30,88 მლნ.
Effective tax rate
22,78%
20,07%
21,77%
23,04%
Other operating expenses
-
-
-
-
Net income
65,88 მლნ.
98,78 მლნ.
79,41 მლნ.
103,16 მლნ.
Net profit margin
20,17%
22,42%
21,32%
23,40%
Earnings per share
0,65
0,98
0,78
1,11
Interest and investment income
2,93 მლნ.
2,81 მლნ.
2,34 მლნ.
2,01 მლნ.
Interest expense
-1,39 მლნ.
-3,49 მლნ.
-
-62,00 ათ.
Net interest expenses
1,54 მლნ.
-677,00 ათ.
2,34 მლნ.
1,95 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
96,10 მლნ.
133,49 მლნ.
101,50 მლნ.
131,21 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები